The Federal Circuit Court of Appeals sent the question of whether damages should be tripled back to the district court, but agreed Zimmer had willfully infringed the patents. The case was previously appealed to the Supreme Court, which said the previous appeals-court standard for enhanced damages was too strict.
The US Court of Appeals for the Federal Circuit has overturned a lower court’s ruling that would have tripled a $70m verdict against Zimmer for violating Stryker wound-care patents, but the court upheld the central finding that Zimmer had willfully infringed the patents.
Stryker filed suit claiming Zimmer’s Pulsavac Plus wound debridement device violated Stryker patents in December 2010. In February 2013, a...
Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.
This week, the FDA announced a new head of its device evaluation office; synthetic genomics firm Constructive Bio landed $58m in funding; and Natera got a permanent injuction against NeoGenomics Labs' RaDaR assay.
Tim Schmid, executive VP and worldwide chairman of J&J MedTech, expects Shockwave, acquired in April, and Abiomed, purchased in late 2022, to be “long-term gems” for the company. Cardiovascular is among higher-growth segments where J&J has concentrated investments in recent years, along with robotic surgical systems.
The US FDA has published a trio of draft guidance documents for its Assessment Scheme for Conformity Program, which began as a pilot in September 2020 to capitalize on the role of standards in the regulation of medical devices.
This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.
Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.
